InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Vera Therapeutics, Inc.

VERA Clue Score36
United States Fiscal year ends December CIK 0001831828 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

9
Insider
Date
Role
Action
Shares
Price
Amount
Laurence Matthew Skelton
23 Feb 2026
Chief Commercial Officer
Sell
1,582
$41.98
$66.42K
William D. Turner
23 Feb 2026
Chief Regulatory Officer
Sell
2,187
$41.98
$91.82K
David Lee Johnson
23 Feb 2026
Chief Operating Officer
Sell
2,579
$41.98
$108.28K
Marshall Fordyce
23 Feb 2026
President and CEO
Sell
16,925
$41.98
$710.58K
Sean Grant
23 Feb 2026
Chief Financial Officer
Sell
4,949
$41.98
$207.78K
Joseph R Young
23 Feb 2026
SVP, Finance, Chief Acct Offcr
Sell
3,117
$41.98
$130.86K
Robert Brenner
23 Feb 2026
Chief Medical Officer
Sell
2,151
$41.98
$90.31K
Jason S Carter
21 Nov 2025
Chief Legal Officer
Sell
3,864
$27.82
$107.50K
Joseph R Young
11 Nov 2025
SVP, Finance, Chief Acct Offcr
Sell
15,000
$29.06
$435.87K
Show all 29 transactions →

What was left out

Form 4 filings counted 40
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 11
Sales straight out of an exercise 5
Sales at will 9
Transactions with no price 0
Shares from compensation/vesting 373,190
History held since 17 May 2021